about
Difference of clinical and radiological characteristics according to radioiodine avidity in pulmonary metastases of differentiated thyroid cancerBiliary Flow in Septate Gallbladder on Hepatobiliary Scintigraphy with SPECT/CT.Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report.Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast CancerImplications of three-phase bone scintigraphy for the diagnosis of bisphosphonate-related osteonecrosis of the jawPrognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast.Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging.Prognostic Value of Metabolic Parameters of 18F-FDG PET/CT and Apparent Diffusion Coefficient of MRI in Hepatocellular Carcinoma.Development of an athyroid mouse model using 131I ablation after preparation with a low-iodine diet.Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.Extracellular vesicles from mesenchymal stem cells activates VEGF receptors and accelerates recovery of hindlimb ischemia.I-131 biokinetics of remnant normal thyroid tissue and residual thyroid cancer in patients with differentiated thyroid cancer: comparison between recombinant human TSH administration and thyroid hormone withdrawal.Emptying effect of massage on parotid gland radioiodine content.Prognostic Significance of Intratumoral Metabolic Heterogeneity on 18F-FDG PET/CT in Pathological N0 Non-Small Cell Lung Cancer.Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.An Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery Vehicles.New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse ModelEarly perfusion and dopamine transporter imaging using F-FP-CIT PET/CT in patients with parkinsonismCan (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablationPreoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancerDistant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptakeSuperiority of delayed risk stratification in differentiated thyroid cancer after total thyroidectomy and radioactive iodine ablationMetabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinomaPROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMAThe Preventive Effect of Parotid Gland Massage on Salivary Gland Dysfunction During High-Dose Radioactive Iodine Therapy for Differentiated Thyroid Cancer: A Randomized Clinical TrialSerum thyroglobulin elevation after needle aspiration of the lymph nodes: the predictive value for detecting metastasis in papillary thyroid cancer patients - a pilot studyA Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid CancerEnhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma
P50
Q33669803-6472B409-9C74-4E35-A6D7-D1450546BB81Q33669974-85941623-5D46-4839-B5AC-EB17B430B54BQ33704137-FE6BE2A7-6A49-4D07-80D1-CF2F17540F03Q33704435-94E5A459-D4FB-402D-93D0-EEB140319448Q33704479-C9BA4ED2-6786-47D2-BED1-B1D8DEEF14BDQ34106024-BD1852C0-424A-449A-978E-D4E0934E293CQ37637322-5B600F30-11AB-47AD-92D5-789F6842807AQ39110786-EF539727-4E98-4BA6-B049-0513CDFC9950Q42378831-9D879483-ADF2-4CBC-B008-EA38F70ECCE9Q45824604-AA117E8E-A6C3-43E4-9BB0-94D5440EE2D9Q45849759-4026CE00-2435-4E99-AE76-9DA7F2C8FD25Q46073511-3DD4EAD4-E2EA-44A0-8A6E-B279B7C9DA1FQ47910382-EDCDA130-5D85-494F-9BAB-0FD244F76DF9Q48177900-A09AA583-0EA8-4CFB-B7E2-E8DC6596B63DQ51120726-2A0997A2-7052-4FF9-BA10-F4CD733FBFBBQ53001557-E274DB40-DCE2-4414-A6C9-247BF2376017Q53095046-C631FA7A-57BD-4C6F-8FED-F404856A0376Q55004583-86C35D97-5824-4415-920B-8DAA845B87EAQ58756331-BD9A9500-4AD4-47F5-9D1F-C74AE57BDEADQ61456002-38219A68-C6FD-4B6C-A137-BE1CB05CA3D3Q83233437-81271953-7277-4459-AD0B-525BE3CB189CQ83396960-7B0976C7-CC83-41CE-8B97-830328C5BE8EQ84504488-893911C1-B683-42AB-AA75-F9635D42D066Q87224357-FE62069B-2D2E-47FE-90DD-E269A725BFEFQ87632523-F85B42F7-3E38-49D5-A7A9-D96AB0B5D95AQ88208036-753B950E-1171-461F-A14A-7A28850D356CQ90231882-8D8E8C0D-76E9-41DA-A07A-DCE8A92289B7Q91633402-4E9CF289-819F-4A47-B09F-3084968AACB6Q92367554-CBD8956B-005D-4161-B5B1-111BEB96D28EQ92581415-7827045F-E4D6-4940-8175-1648879563BFQ92994032-5B63F8F1-872F-4DCC-A175-987D7710C14B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chae Moon Hong
@ast
Chae Moon Hong
@en
Chae Moon Hong
@es
Chae Moon Hong
@nl
Chae Moon Hong
@sl
type
label
Chae Moon Hong
@ast
Chae Moon Hong
@en
Chae Moon Hong
@es
Chae Moon Hong
@nl
Chae Moon Hong
@sl
prefLabel
Chae Moon Hong
@ast
Chae Moon Hong
@en
Chae Moon Hong
@es
Chae Moon Hong
@nl
Chae Moon Hong
@sl
P106
P1153
37050876700
P31
P496
0000-0002-5519-6982